REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Sheba Scientists Have Been Awarded a 2.1 Million USD Grant to Study the Effect of Mitochondria on the Immune System and Microbiome

research
“Hopefully we can improve our understanding of neurodegenerative and metabolic diseases and develop improved treatment options.”

Doctors and scientists at Sheba Medical Center are engaged in a study that recently received significant funding. The research focuses on the effects mitochondrial activity has on the immune system and gut microbiome. Among other things, it examines the reasons behind changes in the composition of the microbiome during various diseases.

Recognizing the importance of the research, The US National Institutes of Health (NIH) granted 2.1 million USD to finance it.

The grant will fund the next step of the study: analyzing the effects that the interaction between mitochondrial activity, the immune system, and the microbiome composition have on cancer development.

Scientists work  on the study to find out how mitochondria affect the immune system

According to Dr. Tal Yardeni, head of the newly-founded Mitochondrial Research Lab at Sheba and one of the lead researchers: “The NIH’s recognition of the importance of the mitochondrial activity’s impact on the gut microbiome and the immune system is part of a paradigm shift in medicine. I hope that, through this research, we can improve our understanding of neurodegenerative and metabolic diseases, resulting in new and improved treatment options for patients”.

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More